A panel of experts from the American Lung Cancer Association and the American Thoracic Society (ATS) has developed a new lung cancer screening guide for clinicians that see patients at risk of developing lung cancer. According to Michael A. Pritchett, D.O., MPH, of FirstHealth of the Carolinas and Pinehurst Medical Clinic in Pinehurst, North Carolina, 75 percent of lung cancers are found at stage III or IV where they are inoperable. The National Lung Screening trial found that the mortality rate can be reduced by 20 percent by implementing low-dose screenings with CT scans.
“All the major societies have agreed that this is useful and can really create what’s called a stage shift. We want to shift that and flip those numbers, so at least 75 percent of patients are found at stage I or stage II [and] we can do surgery or just radiation therapy,” added Dr. Pritchett.
Dr. Pritchett was part of the FirstHealth of the Carolinas team that made the decision to invest in the HealthMyne Platform to advance multiple oncology-related programs, including lung cancer screening and tumor conferences. FirstHealth is the first in the region to implement HealthMyne, which is the only platform on the market that combines quantitative imaging data with clinical information to power improved collaboration and communication between providers and patients.